Published in Diabetes Care on May 20, 2011
Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients. Oxid Med Cell Longev (2016) 1.38
Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. Diabetes (2012) 1.07
A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups. Curr Diabetes Rev (2013) 1.06
Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J Diabetes (2012) 0.98
An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database. Clin Epidemiol (2016) 0.93
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) (2014) 0.90
Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin Epidemiol (2012) 0.88
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). J Diabetes Complications (2013) 0.84
Redox homeostasis in pancreatic β cells. Oxid Med Cell Longev (2012) 0.82
Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes (2013) 0.80
Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer. Cell Cycle (2013) 0.79
Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents. Drugs Context (2014) 0.79
Diabetes treatment in 2025: can scientific advances keep pace with prevalence? Ther Adv Endocrinol Metab (2012) 0.79
Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030. Popul Health Metr (2013) 0.78
Joint effects of serum ferritin and body mass index on the risk of coronary artery disease: a case-control study. BMJ Open (2013) 0.77
Glycemic control rate of T2DM outpatients in China: a multi-center survey. Med Sci Monit (2015) 0.77
Overweight, resting heart rate, and prediabetes/diabetes: A population-based prospective cohort study among Inner Mongolians in China. Sci Rep (2016) 0.76
Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice. Stem Cell Res Ther (2015) 0.76
Network Based Approach in the Establishment of the Relationship between Type 2 Diabetes Mellitus and Its Complications at the Molecular Level Coupled with Molecular Docking Mechanism. Biomed Res Int (2016) 0.75
The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Arch Public Health (2016) 0.75
Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications. Stem Cells Int (2016) 0.75
Evidence summary: The relationship between oral diseases and diabetes. Br Dent J (2017) 0.75
A reliability assessment of a direct-observation park evaluation tool: the parks, activity and recreation among kids (PARK) tool. BMC Public Health (2015) 0.75
Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice. BMC Cardiovasc Disord (2015) 0.75
Replication of Early B-cell Factor 1 (EBF1) Gene-by-psychosocial Stress Interaction Effects on Central Adiposity in a Korean Population. J Prev Med Public Health (2016) 0.75
Methionine sulfoxide reductase B1 deficiency does not increase high-fat diet-induced insulin resistance in mice. Free Radic Res (2016) 0.75
Longer sleep is associated with lower BMI and favorable metabolic profiles in UK adults: Findings from the National Diet and Nutrition Survey. PLoS One (2017) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes (2003) 16.62
Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 15.48
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Initial impact of the sequencing of the human genome. Nature (2011) 9.18
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med (2010) 5.86
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol (2008) 5.61
Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med (2002) 4.69
Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet (1997) 4.40
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res (1985) 4.39
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Clinical practice. Treatment of tobacco use and dependence. N Engl J Med (2002) 3.88
Metabolic implications of body fat distribution. Diabetes Care (1991) 3.28
Angiogenesis modulates adipogenesis and obesity. J Clin Invest (2007) 3.23
Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21
Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06
Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes (2007) 2.91
Increased islet apoptosis in Pdx1+/- mice. J Clin Invest (2003) 2.91
Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab (2010) 2.90
The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest (1967) 2.87
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med (2010) 2.17
Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci (2010) 2.16
Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med (2009) 2.02
Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest (1988) 2.01
Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology (2010) 1.77
Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med (2008) 1.61
Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes (2010) 1.42
Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. J Clin Endocrinol Metab (2010) 1.34
Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg (2010) 1.19
Retracted Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem (2011) 1.16
Missing heritability and GWAS utility. Obesity (Silver Spring) (2009) 1.15
TNF-alpha is required for the attraction of mesenchymal precursors to white adipose tissue in Ob/ob mice. PLoS One (2009) 1.06
The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06
The effect of protein and glycemic index on children's body composition: the DiOGenes randomized study. Pediatrics (2010) 1.05
Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia (2010) 1.03
IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes. Diabetes (2001) 0.95
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2005) 11.91
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 8.92
Diagnosis and classification of diabetes mellitus. Diabetes Care (2004) 8.66
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Diagnosis and classification of diabetes mellitus. Diabetes Care (2014) 8.37
Diagnosis and classification of diabetes mellitus. Diabetes Care (2008) 8.16
Diagnosis and classification of diabetes mellitus. Diabetes Care (2006) 7.91
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 7.66
A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med (2012) 7.51
Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
Standards of medical care in diabetes. Diabetes Care (2005) 5.98
Gestational diabetes mellitus. Diabetes Care (2004) 5.77
The human serum metabolome. PLoS One (2011) 5.55
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem (2003) 5.40
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature (2003) 5.27
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res (2007) 4.92
Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Diagnosis and classification of diabetes mellitus. Diabetes Care (2007) 4.78
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 4.73
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.68
Standards of medical care for patients with diabetes mellitus. Diabetes Care (2003) 4.64
Paget's disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 4.63
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Diagnosis and classification of diabetes mellitus. Diabetes Care (2005) 4.47
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Peripheral arterial disease in people with diabetes. Diabetes Care (2003) 4.36
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet (2012) 4.33
Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care (2008) 4.32
Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA (2012) 4.30
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
(2) Classification and diagnosis of diabetes. Diabetes Care (2015) 4.29
Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab (2008) 4.29
Screening for type 2 diabetes. Diabetes Care (2004) 4.27
Retinopathy in diabetes. Diabetes Care (2004) 4.25
Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17
Nephropathy in diabetes. Diabetes Care (2004) 4.08
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes (2004) 4.04
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2009) 4.04
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.02
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care (2002) 3.96
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
Standards of medical care in diabetes. Diabetes Care (2004) 3.95
Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med (2007) 3.92